subject: CHEBI:94366

subject_name: itraconazole

object_name: allergic bronchopulmonary aspergillosis


subject: CHEBI:2549

subject_name: Albuterol

object_name: pulmonary hypertension, primary, 1

tested_intervention: yes


subject: CHEBI:2549

object_name: pulmonary hypertension


subject: CHEBI:2549

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:2549

object_name: pulmonary arterial hypertension


subject: CHEBI:41423

subject_name: Celecoxib

object_name: bladder tumor

tested_intervention: unsure


subject: CHEBI:41423

object_name: urinary bladder carcinoma


subject: CHEBI:41423

object_name: urinary bladder cancer


subject: CHEBI:41423

object_name: childhood bladder carcinoma


subject: UNII:F64QU97QCR

subject_name: Dantrolene

object_name: multiple sclerosis


subject: CHEBI:8228

subject_name: Pioglitazone


subject: CHEBI:32016

subject_name: Pirfenidone


subject: PUBCHEM.COMPOUND:2781

subject_name: Meclastine


subject: CHEBI:3738

subject_name: Clemastine


subject: UMLS:C2718754

subject_name: Ilaris

object_name: CINCA syndrome


subject: UMLS:C2718754

object_name: Muckle-Wells syndrome


subject: UMLS:C2718754

object_name: cryopyrin-associated periodic syndrome


subject: UMLS:C2718754

object_name: familial cold autoinflammatory syndrome


subject: PUBCHEM.COMPOUND:121362450

object_name: cardiovascular disorder


subject: CHEBI:15940

subject_name: Niacin


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:91951

object_name: EXCESS LMW-DNA


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Alzheimer disease


subject: CHEBI:3723

subject_name: Citalopram


subject: GTOPDB:13497

subject_name: axatilimab

object_name: juvenile myelomonocytic leukemia


subject: GTOPDB:13497

object_name: chronic myelomonocytic leukemia


subject: GTOPDB:13497


subject: GTOPDB:13497

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: GTOPDB:13497

object_name: Recurrent Myeloproliferative Neoplasm


subject: GTOPDB:13497

object_name: Refractory Myeloproliferative Neoplasm


subject: GTOPDB:13497

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEMBL.COMPOUND:CHEMBL4594608

subject_name: AXATILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594608


subject: CHEMBL.COMPOUND:CHEMBL4594608


subject: CHEMBL.COMPOUND:CHEMBL4594608


subject: CHEMBL.COMPOUND:CHEMBL4594608


subject: CHEMBL.COMPOUND:CHEMBL4594608


subject: CHEMBL.COMPOUND:CHEMBL4594608


subject: UMLS:C4733597


subject: UMLS:C4733597


subject: UMLS:C4733597


subject: UMLS:C4733597


subject: UMLS:C4733597


subject: UMLS:C4733597


subject: UMLS:C4733597


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-


subject: PUBCHEM.COMPOUND:1805


subject: PUBCHEM.COMPOUND:1805


subject: PUBCHEM.COMPOUND:1805


subject: PUBCHEM.COMPOUND:1805


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:3996

subject_name: Cyclobenzaprine

object_name: Acute low back pain


subject: CHEBI:59527


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:7852

subject_name: Oxycodone


subject: CHEBI:46195

subject_name: Acetaminophen


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Fractional Flow Reserve of Vessel


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: Sepsis


subject: UMLS:C3540708

object_name: Sepsis, CTCAE


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: MESH:D000904


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540709


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540707


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540704


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540706


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540710


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C3540705


subject: UMLS:C4721782

subject_name: Pegargiminase

object_name: liver carcinoma


subject: UMLS:C4721782

object_name: Stomach cancer


subject: UMLS:C4721782

object_name: gastric cancer


subject: UMLS:C4721782

object_name: colorectal cancer


subject: UMLS:C4721782

object_name: colorectal carcinoma


subject: UMLS:C4721782

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1328192

subject_name: ADI PEG20


subject: UMLS:C1328192


subject: UMLS:C1328192


subject: UMLS:C1328192


subject: UMLS:C1328192


subject: UMLS:C1328192


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: aortic aneurysm


subject: CHEBI:60648

object_name: Aortic aneurysm without mention of rupture NOS


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: UMLS:C5706535

subject_name: RET Inhibitor EP0031

object_name: non-small cell lung carcinoma


subject: UMLS:C5706535

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:1971

subject_name: ent-Abacavir

object_name: tuberculosis


subject: PUBCHEM.COMPOUND:1971

object_name: HIV infection


subject: CHEBI:421707

subject_name: Abacavir


subject: CHEBI:421707


subject: CHEBI:2549

subject_name: Albuterol

object_name: sickle cell disease


subject: PUBCHEM.COMPOUND:131751553

subject_name: Morellinol

object_name: Cirrhosis


subject: PUBCHEM.COMPOUND:131751553

object_name: liver cirrhosis


subject: CHEBI:176233

subject_name: Tocophersolan


subject: CHEBI:176233


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: UNII:O03S90U1F2

subject_name: Tocofersolan


subject: UNII:O03S90U1F2


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: CHEBI:80630

subject_name: Irinotecan

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: CHEBI:80630

object_name: digestive system neuroendocrine neoplasm


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:93109

subject_name: Semaxanib

object_name: cervical cancer


subject: CHEBI:93109

object_name: cervical carcinoma


subject: CHEBI:91083

subject_name: Romiplostim


subject: CHEBI:91083


subject: CHEBI:57858

subject_name: atropinium

object_name: Difficult tracheal intubation (finding)


subject: CHEBI:92712

subject_name: ENDO-ATROPINE


subject: CHEBI:91541


subject: UMLS:C1161352

subject_name: Atropinum, atropine


subject: UMLS:C0021735

subject_name: Viraferon

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C0021735

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C0021735

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C0021735

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UMLS:C0021735

object_name: Stage III renal cell cancer


subject: UMLS:C0021735

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UMLS:C0021735

object_name: Renal cell carcinoma recurrent


subject: UMLS:C0021735

object_name: Renal cancer recurrent


subject: UMLS:C0021735

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C0021735

object_name: clear cell renal carcinoma


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:499361

subject_name: Aprepitant

object_name: Primary malignant neoplasm


subject: CHEBI:499361

object_name: cancer


subject: CHEBI:499361

object_name: childhood malignant neoplasm


subject: CHEBI:499361

object_name: Malignant obstetric neoplasm


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:7773


subject: UNII:YZS3R7LP44

subject_name: Palonosetron


subject: UNII:YZS3R7LP44


subject: UNII:YZS3R7LP44


subject: UNII:YZS3R7LP44


subject: CHEBI:6801

subject_name: Metformin

object_name: diabetes insipidus


subject: PUBCHEM.COMPOUND:21628493

subject_name: ESTROGEN

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:21628493

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:21628493

object_name: breast cancer


subject: PUBCHEM.COMPOUND:21628493

object_name: Vulvovaginal Atrophy


subject: CHEBI:50114

subject_name: estrogen


subject: CHEBI:50114


subject: CHEBI:50114


subject: CHEBI:50114


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:4903


subject: CHEBI:4903


subject: CHEBI:4903


subject: UMLS:C2936882

subject_name: Estrogen [EPC]


subject: UMLS:C2936882


subject: UMLS:C2936882


subject: UMLS:C2936882


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone


subject: UMLS:C4508945

object_name: leiomyoma


subject: CHEBI:231683

subject_name: Anakinra


subject: CHEBI:231683

object_name: cytokine release syndrome


subject: CHEBI:231683

object_name: Cytokine storm


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: PR:000001137


subject: UNII:4Y05SI704S

subject_name: SOMAVARATAN

object_name: Congenital IGHD


subject: UNII:4Y05SI704S

object_name: Reduced circulating growth hormone concentration


subject: UMLS:C4519725

subject_name: Somavaratan


subject: UMLS:C4519725


subject: UNII:9D6YZ105SN

subject_name: ornithine phenylacetate

object_name: hepatic encephalopathy


subject: UMLS:C3492240


subject: DRUGBANK:DB17524

object_name: urothelial carcinoma


subject: DRUGBANK:DB17524

object_name: transitional cell carcinoma


subject: UNII:OJE5810C4F

subject_name: Taxoprexin

object_name: metastatic melanoma


subject: UMLS:C1135143


subject: PUBCHEM.COMPOUND:86305217

subject_name: DALZANEMDOR

object_name: Parkinson disease


subject: PUBCHEM.COMPOUND:86305217

object_name: Cognitive impairment


subject: CHEBI:7862

subject_name: Oxymetazoline

object_name: common cold


subject: CHEMBL.COMPOUND:CHEMBL4297772


subject: CHEMBL.COMPOUND:CHEMBL4297772

object_name: lymphopenia


subject: CHEBI:32599

object_name: brain aneurysm


subject: PUBCHEM.COMPOUND:90488848

object_name: Conn's syndrome


subject: CHEBI:3892

subject_name: Corticotropin


subject: UMLS:C0718234

subject_name: Acthar


subject: UMLS:C2825093

subject_name: Adrenocorticotropic Hormone [EPC]


subject: CHEBI:59585

object_name: osteoarthritis, hip


subject: UMLS:C0162357

subject_name: Clodronate


subject: CHEBI:110423

subject_name: Clodronic acid


subject: UMLS:C4053576

subject_name: Immunotherapeutic Combination Product CMB305

object_name: melanoma


subject: UMLS:C4053576

object_name: non-small cell lung carcinoma


subject: UMLS:C4053576

object_name: ovarian cancer


subject: UMLS:C4053576

object_name: ovarian neoplasm


subject: UMLS:C4053576

object_name: ovarian carcinoma


subject: UMLS:C4053576

object_name: malignant soft tissue neoplasm


subject: UMLS:C4053576

object_name: sarcoma


subject: PUBCHEM.COMPOUND:56998


subject: PUBCHEM.COMPOUND:56998


subject: PUBCHEM.COMPOUND:56998


subject: PUBCHEM.COMPOUND:56998


subject: PUBCHEM.COMPOUND:56998


subject: PUBCHEM.COMPOUND:56998


subject: PUBCHEM.COMPOUND:56998


subject: PUBCHEM.COMPOUND:70105374

subject_name: Pitavastatin Lactone

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:70105374

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:70105374

object_name: Hypercholesterolemia


subject: CHEBI:32020

subject_name: Pitavastatin


subject: CHEBI:32020


subject: CHEBI:32020


subject: CHEBI:71219

subject_name: Pazopanib

object_name: carcinosarcoma of the corpus uteri


subject: CHEBI:71219

object_name: uterine carcinosarcoma


subject: CHEBI:71219

object_name: Recurrent Uterine Corpus Sarcoma


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: mast cell leukemia


subject: UNII:7XL5ISS668

object_name: systemic mastocytosis


subject: UNII:7XL5ISS668

object_name: aggressive systemic mastocytosis


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Congenital IGHD


subject: CHEBI:8228

object_name: Reduced circulating growth hormone concentration


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:52717

object_name: EBV Infection


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:53076

object_name: colorectal cancer


subject: CHEBI:53076

object_name: colorectal carcinoma


subject: CHEBI:53076

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C2342719

subject_name: calcium levofolinate


subject: UMLS:C2342719


subject: UMLS:C2342719


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:4026

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:4026

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:4026

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:4026

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:4026

object_name: Carcinoma breast stage IV


subject: CHEBI:4026

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:4026

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:91872


subject: CHEBI:91872

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:91872

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:91872

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:91872

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:91872

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:91872


subject: CHEBI:91872

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:91872

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:91872

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:28748

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:28748

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:28748

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:28748


subject: CHEBI:28748

object_name: Carcinoma breast stage IV


subject: CHEBI:28748

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:28748

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: UMLS:C3540795

subject_name: ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS


subject: UMLS:C3540795

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C3540795

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C3540795

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C3540795


subject: UMLS:C3540795


subject: UMLS:C3540795


subject: UMLS:C3540795

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C3540795

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C3540795


subject: UMLS:C3540795


subject: UMLS:C3540795

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C3540795


subject: UMLS:C3540795


subject: UMLS:C3540795

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C3540795

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C3540795


subject: UMLS:C3540795

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C3540795

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C3540795

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:45863

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:45863

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:45863


subject: CHEBI:45863

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:231601

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:231601

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:231601

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:231601

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:231601


subject: CHEBI:231601

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:231601

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:231601

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage IIA Breast Carcinoma


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F

object_name: Stage IIB Breast Carcinoma


subject: UNII:SE2KH7T06F

object_name: malignant neoplasm of breast stage IIb


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F

object_name: Stage IIIA Breast Carcinoma


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C0338204

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C0338204

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C0338204

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C0338204

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C0338204


subject: UMLS:C0338204

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C0338204

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C0338204

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Hunger


subject: PUBCHEM.COMPOUND:155543961

object_name: Weight loss


subject: PUBCHEM.COMPOUND:155543961

object_name: Weight Loss, CTCAE


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: CHEBI:63660

object_name: acute myocardial infarction


subject: CHEBI:63660

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:63618


subject: CHEBI:7852

subject_name: Oxycodone

object_name: opiate dependence


subject: UMLS:C4080100

object_name: Alzheimer disease type 1


subject: UMLS:C4080100

object_name: Alzheimer disease


subject: PUBCHEM.COMPOUND:72809956

subject_name: QS 21


subject: PUBCHEM.COMPOUND:72809956


subject: CHEMBL.COMPOUND:CHEMBL4297817


subject: CHEMBL.COMPOUND:CHEMBL4297817


subject: CHEBI:52717

object_name: Acute lymphoblastic leukemia, in relapse


subject: CHEBI:52717

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:52717

object_name: Acute lymphoblastic leukemia with failed remission


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: hip fracture


subject: UMLS:C4086546

object_name: Control of hip fracture risk


subject: UMLS:C4086546

object_name: familial avascular necrosis of femoral head


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:3215


subject: CHEBI:3215


subject: PUBCHEM.COMPOUND:20802597

subject_name: Sapacitabine

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:20802597

object_name: leukemia


subject: PUBCHEM.COMPOUND:2269

object_name: cytokine release syndrome


subject: PUBCHEM.COMPOUND:2269

object_name: Cytokine storm


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: UMLS:C2095490

subject_name: corticosteroid injection

object_name: viral pneumonia


subject: UMLS:C2095490


subject: UMLS:C2095490


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:5801


subject: CHEBI:31781

subject_name: Lopinavir


subject: CHEBI:31781


subject: CHEBI:31781


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:45409


subject: CHEBI:45409


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight


subject: MESH:D006495


subject: MESH:D006495


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UMLS:C3536766


subject: UMLS:C3536766


subject: UNII:X00B0D5O0E

subject_name: PIPERACILLIN


subject: UNII:X00B0D5O0E


subject: UNII:X00B0D5O0E


subject: CHEBI:8232

subject_name: Piperacillin


subject: CHEBI:8232


subject: CHEBI:8232


subject: CHEBI:9421

subject_name: Tazobactam


subject: CHEBI:9421


subject: CHEBI:9421


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: CHEBI:2948

subject_name: Azathioprine

object_name: thrombocytopenia


subject: CHEBI:5801


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: MESH:C000628612

object_name: breast neoplasm


subject: MESH:C000628612

object_name: breast cancer


subject: GTOPDB:11182

subject_name: concizumab

object_name: hemophilia A


subject: GTOPDB:11182

object_name: hemophilia B


subject: CHEMBL.COMPOUND:CHEMBL4297730

subject_name: CONCIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297730


subject: UMLS:C3494079


subject: UMLS:C3494079


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:46195

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:124959

subject_name: Tilarginine

object_name: glomerulonephritis


subject: CHEBI:124959

object_name: autosomal dominant polycystic kidney disease


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: CHEBI:49668

subject_name: Gefitinib

object_name: renal pelvis/ureter urothelial carcinoma


subject: CHEBI:49668

object_name: carcinoma of urethra


subject: CHEBI:49668

object_name: urethra cancer


subject: CHEBI:49668

object_name: bladder tumor


subject: CHEBI:49668

object_name: urinary bladder carcinoma


subject: CHEBI:49668

object_name: urinary bladder cancer


subject: CHEBI:49668

object_name: childhood bladder carcinoma


subject: CHEBI:32010

subject_name: Piracetam

object_name: cocaine abuse


subject: CHEBI:51230

subject_name: Bimatoprost

object_name: alopecia areata


subject: CHEBI:51230

object_name: alopecia


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: otosclerosis


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Recurrent ovarian cancer


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: multiple sclerosis


subject: CHEBI:68575

subject_name: Indacaterol

object_name: asthma


subject: UNII:90YLS47BRX

object_name: Myelodysplasia


subject: UNII:90YLS47BRX

object_name: chronic myelomonocytic leukemia


subject: UNII:90YLS47BRX

object_name: acute myeloid leukemia


subject: CHEMBL.COMPOUND:CHEMBL4802174


subject: CHEMBL.COMPOUND:CHEMBL4802174


subject: CHEMBL.COMPOUND:CHEMBL4802174


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:35155

subject_name: elemental calcium

object_name: Depressed mood


subject: CHEBI:35155

object_name: Cancer patients and suicide and depression


subject: CHEBI:35155

object_name: Depressed - symptom


subject: CHEBI:35155

object_name: Depression, CTCAE


subject: CHEBI:35155

object_name: Maternity blues


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:22984


subject: CHEBI:22984


subject: CHEBI:22984


subject: CHEBI:22984


subject: CHEBI:50634

object_name: intracranial hypertension


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:10023

subject_name: Voriconazole

object_name: systemic mycosis


subject: GTOPDB:8002

subject_name: bavituximab

object_name: male breast carcinoma


subject: GTOPDB:8002

object_name: Her2-receptor negative breast cancer


subject: GTOPDB:8002

object_name: Stage IIIC Breast Cancer AJCC v6


subject: GTOPDB:8002

object_name: Stage IIIC Breast Cancer AJCC v7


subject: GTOPDB:8002

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: GTOPDB:8002

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: GTOPDB:8002

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: GTOPDB:8002

object_name: Carcinoma breast stage IV


subject: GTOPDB:8002

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: GTOPDB:8002

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: GTOPDB:8002

object_name: Breast cancer recurrent


subject: UNII:Q16CT95N25


subject: UNII:Q16CT95N25


subject: UNII:Q16CT95N25


subject: UNII:Q16CT95N25


subject: UNII:Q16CT95N25


subject: UNII:Q16CT95N25


subject: UNII:Q16CT95N25


subject: UNII:Q16CT95N25


subject: UNII:Q16CT95N25


subject: UNII:Q16CT95N25


subject: UNII:Q16CT95N25


subject: UMLS:C1707382


subject: UMLS:C1707382


subject: UMLS:C1707382


subject: UMLS:C1707382


subject: UMLS:C1707382


subject: UMLS:C1707382


subject: UMLS:C1707382


subject: UMLS:C1707382


subject: UMLS:C1707382


subject: UMLS:C1707382


subject: UMLS:C1707382


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: bone cancer


subject: PUBCHEM.COMPOUND:6096882

object_name: bone neoplasm


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: CHEBI:234112

subject_name: Cenobamate

object_name: focal epilepsy


subject: CHEBI:124959

subject_name: Tilarginine

object_name: Gastrointestinal motility disorder


subject: CHEBI:124959

object_name: Disturbance of salivary secretion


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Vestibulodynia


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: juvenile idiopathic arthritis


subject: UMLS:C4551750

subject_name: Aprovel

object_name: hypertension


subject: UMLS:C4551750

object_name: Hypertension, CTCAE


subject: CHEBI:74699

subject_name: Met-Asp

object_name: Huntington disease


subject: CHEBI:33395

subject_name: Mendelevium


subject: CHEBI:6823

subject_name: Methdilazine


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: toothache


subject: GTOPDB:9340

subject_name: ontamalimab

object_name: Crohn disease


subject: UNII:6LGI7RV4PB


subject: UMLS:C5139910


subject: CHEBI:71954

subject_name: Buparlisib

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: CHEBI:71954

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:71954

object_name: tongue cancer


subject: CHEBI:71954

object_name: tongue carcinoma


subject: CHEBI:71954

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:71954

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:71954

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:71954

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:71954

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:71954

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:71954

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: CHEBI:71954

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:71954

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:71954

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:71954

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:71954

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:71954

object_name: stage IVA squamous cell carcinoma of the larynx


subject: CHEBI:71954

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:71954

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:71954

object_name: stage IVC squamous cell carcinoma of the larynx


subject: CHEBI:71954

object_name: stage IVB squamous cell carcinoma of the larynx


subject: CHEBI:71954

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:71954

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:71954

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:71954

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:71954

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:71954

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:71954

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:71954

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: CHEBI:71954

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: CHEBI:71954

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:71954

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:71954

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:71954

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: CHEBI:71954

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: CHEBI:71954

object_name: stage IVA salivary gland cancer


subject: CHEBI:71954

object_name: stage IVC salivary gland cancer


subject: CHEBI:71954

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: CHEBI:71954

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: CHEBI:71954

object_name: stage IVB salivary gland cancer


subject: CHEBI:71954

object_name: salivary gland squamous cell carcinoma


subject: CHEBI:71954

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:71954

object_name: stage IVC verrucous carcinoma of the larynx


subject: CHEBI:71954

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:71954

object_name: stage IVB verrucous carcinoma of the larynx


subject: CHEBI:71954

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:71954

object_name: stage IVA verrucous carcinoma of the larynx


subject: CHEBI:71954

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: CHEBI:71954

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: CHEBI:71954

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: UNII:PQX0D8J21J

object_name: Recurrent Salivary Gland Cancer


subject: UNII:PQX0D8J21J

object_name: tongue cancer


subject: UNII:PQX0D8J21J

object_name: tongue carcinoma


subject: UNII:PQX0D8J21J

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: UNII:PQX0D8J21J

object_name: Laryngeal verrucous carcinoma recurrent


subject: UNII:PQX0D8J21J

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UNII:PQX0D8J21J

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: UNII:PQX0D8J21J

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UNII:PQX0D8J21J

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: UNII:PQX0D8J21J

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:PQX0D8J21J

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:PQX0D8J21J

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:PQX0D8J21J

object_name: stage IVA squamous cell carcinoma of the larynx


subject: UNII:PQX0D8J21J

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:PQX0D8J21J

object_name: stage IVC squamous cell carcinoma of the larynx


subject: UNII:PQX0D8J21J

object_name: stage IVB squamous cell carcinoma of the larynx


subject: UNII:PQX0D8J21J

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:PQX0D8J21J

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: UNII:PQX0D8J21J

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: UNII:PQX0D8J21J

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: UNII:PQX0D8J21J

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:PQX0D8J21J

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: UNII:PQX0D8J21J

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: UNII:PQX0D8J21J

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:PQX0D8J21J

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: UNII:PQX0D8J21J

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:PQX0D8J21J

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: UNII:PQX0D8J21J

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: stage IVA salivary gland cancer


subject: UNII:PQX0D8J21J

object_name: stage IVC salivary gland cancer


subject: UNII:PQX0D8J21J

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: stage IVB salivary gland cancer


subject: UNII:PQX0D8J21J

object_name: salivary gland squamous cell carcinoma


subject: UNII:PQX0D8J21J

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: UNII:PQX0D8J21J

object_name: stage IVC verrucous carcinoma of the larynx


subject: UNII:PQX0D8J21J

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: UNII:PQX0D8J21J

object_name: stage IVB verrucous carcinoma of the larynx


subject: UNII:PQX0D8J21J

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: UNII:PQX0D8J21J

object_name: stage IVA verrucous carcinoma of the larynx


subject: UNII:PQX0D8J21J

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: UNII:PQX0D8J21J

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: UNII:PQX0D8J21J

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: UMLS:C0879636

subject_name: IMC C225

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: UMLS:C0879636

object_name: Recurrent Salivary Gland Cancer


subject: UMLS:C0879636

object_name: tongue cancer


subject: UMLS:C0879636

object_name: tongue carcinoma


subject: UMLS:C0879636

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: UMLS:C0879636

object_name: Laryngeal verrucous carcinoma recurrent


subject: UMLS:C0879636

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UMLS:C0879636

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: UMLS:C0879636

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UMLS:C0879636

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: UMLS:C0879636

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UMLS:C0879636

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UMLS:C0879636

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UMLS:C0879636

object_name: stage IVA squamous cell carcinoma of the larynx


subject: UMLS:C0879636

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C0879636

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C0879636

object_name: stage IVC squamous cell carcinoma of the larynx


subject: UMLS:C0879636

object_name: stage IVB squamous cell carcinoma of the larynx


subject: UMLS:C0879636

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C0879636

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: UMLS:C0879636

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: UMLS:C0879636

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: UMLS:C0879636

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C0879636

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C0879636

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: UMLS:C0879636

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: UMLS:C0879636

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C0879636

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: UMLS:C0879636

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C0879636

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: UMLS:C0879636

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: UMLS:C0879636

object_name: stage IVA salivary gland cancer


subject: UMLS:C0879636

object_name: stage IVC salivary gland cancer


subject: UMLS:C0879636

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: UMLS:C0879636

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: UMLS:C0879636

object_name: stage IVB salivary gland cancer


subject: UMLS:C0879636

object_name: salivary gland squamous cell carcinoma


subject: UMLS:C0879636

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: UMLS:C0879636

object_name: stage IVC verrucous carcinoma of the larynx


subject: UMLS:C0879636

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: UMLS:C0879636

object_name: stage IVB verrucous carcinoma of the larynx


subject: UMLS:C0879636

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: UMLS:C0879636

object_name: stage IVA verrucous carcinoma of the larynx


subject: UMLS:C0879636

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: UMLS:C0879636

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: UMLS:C0879636

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: CHEBI:36121

subject_name: flavylium

object_name: type 2 diabetes mellitus


subject: CHEBI:36121

object_name: diabetes mellitus, noninsulin-dependent, 2


subject: CHEBI:36121

object_name: maturity-onset diabetes of the young type 1


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: Childhood Neuroblastoma


subject: CHEBI:49900

object_name: neuroblastoma


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: Weight Change


subject: CHEBI:30742

subject_name: macrogol

object_name: Constipation


subject: CHEBI:30742

object_name: Constipation, CTCAE


subject: CHEBI:93776

subject_name: Pevonedistat

object_name: Myelodysplasia


subject: CHEBI:93776

object_name: chronic myelomonocytic leukemia


subject: CHEBI:93776

object_name: acute myeloid leukemia


subject: CHEBI:6456

subject_name: Lidocaine

object_name: pulmonary hypertension


subject: CHEBI:28487

subject_name: Reserpine


subject: CHEBI:31547

subject_name: Eplerenone

object_name: Chronic uremia


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Primary hypercholesterolemia


subject: UNII:7LBRZUYSHU

subject_name: Branebrutinib

object_name: rheumatoid arthritis


subject: UMLS:C5139941


subject: CHEBI:7627

subject_name: Norethisterone


subject: UMLS:C3502292

subject_name: cenderitide

object_name: heart failure


subject: UMLS:C3502292

object_name: Heart Failure, CTCAE


subject: UMLS:C3502292

object_name: kidney failure


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: rickets


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C4508451

subject_name: Xanamem

object_name: cortisol measurement


subject: UMLS:C4508451

object_name: neuropathy, small fiber


subject: UMLS:C4508451

object_name: primary erythermalgia


subject: UMLS:C4508451

object_name: peripheral nervous system disorder


subject: UMLS:C4508451

object_name: neuropathy


subject: UMLS:C4508451

object_name: electrocardiography


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: healthy, no evidence of disease


subject: UMLS:C1704263

subject_name: green tea extract


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: UMLS:C3152308

subject_name: Polygonum cuspidatum extract


subject: UMLS:C2936926

subject_name: ZK-epothilone

object_name: melanoma


subject: DRUGBANK:DB18453

object_name: hypoparathyroidism


subject: DRUGBANK:DB18453

object_name: Hypoparathyroidism, CTCAE


subject: CHEBI:71954

subject_name: Buparlisib

object_name: Squamous cell carcinoma of head and neck metastatic


subject: CHEBI:71954

object_name: Squamous cell carcinoma of head and neck recurrent


subject: CHEBI:6801

subject_name: Metformin

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:6801

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:6801

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:6801

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:6801

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:6801

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:6801

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:6801

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:6801

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:6801

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:6801

object_name: adult acute monocytic leukemia


subject: CHEBI:6801

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:6801

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:6801

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:6801

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:6801

object_name: Adult Erythroleukemia


subject: CHEBI:6801

object_name: Blast Phase


subject: CHEBI:33325

subject_name: radium atom

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C3827153


subject: UMLS:C1442960

subject_name: Turkey antigen

object_name: Post-Operative Pain


subject: DRUGBANK:DB10575

subject_name: Turkey


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: lupus nephritis


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:4875

subject_name: Etanercept

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:4875

object_name: metabolic syndrome X


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: GTOPDB:9674

subject_name: olaptesed pegol

object_name: glioblastoma


subject: GTOPDB:9674

object_name: Childhood Glioblastoma


subject: GTOPDB:9674

object_name: adult glioblastoma


subject: UNII:MTM792B442

subject_name: OLAPTESED PEGOL


subject: UNII:MTM792B442


subject: UNII:MTM792B442


subject: CHEBI:6801

object_name: pelvic pain on the left


subject: CHEBI:6801

object_name: pelvic pain occurs with urination


subject: CHEBI:6801

object_name: pelvic pain occurs with bowel movement


subject: CHEBI:6801

object_name: pelvic pain decreasing in severity


subject: CHEBI:6801

object_name: Pelvic pain female


subject: CHEBI:6801

object_name: pelvic pain increasing in severity


subject: CHEBI:6801

object_name: male pelvic pain


subject: CHEBI:6801

object_name: pelvic pain to the rear


subject: CHEBI:6801

object_name: pelvic pain on the right


subject: CHEBI:6801

object_name: pelvic pain decreasing in frequency


subject: CHEBI:6801

object_name: Pelvic pain


subject: CHEBI:6801

object_name: Pelvic Pain, CTCAE 5.0


subject: CHEBI:6801

object_name: pelvic pain causes awakening at night


subject: CHEBI:6801

object_name: pelvic pain increasing in frequency


subject: CHEBI:6801

object_name: pelvic pain occurs with intercourse


subject: CHEBI:6801

object_name: pelvic pain in front


subject: CHEBI:6801

object_name: endometriosis


subject: CHEBI:8988

object_name: neuroendocrine neoplasm


subject: CHEBI:8988

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: CHEBI:8988

object_name: pancreatic adenocarcinoma


subject: CHEBI:8988

object_name: ovarian carcinoma


subject: CHEBI:8988

object_name: endometrial carcinoma


subject: CHEBI:8988

object_name: glioblastoma


subject: CHEBI:8988

object_name: Childhood Glioblastoma


subject: CHEBI:8988

object_name: adult glioblastoma


subject: CHEBI:8988

object_name: Mesothelioma


subject: CHEBI:8988

object_name: mesothelial neoplasm


subject: CHEBI:8988

object_name: malignant mesothelioma


subject: CHEBI:8988

object_name: small cell carcinoma


subject: CHEBI:8988

object_name: small cell lung carcinoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: UNII:2CN60TN6ZS

subject_name: Lurbinectedin


subject: UNII:2CN60TN6ZS


subject: UNII:2CN60TN6ZS


subject: UNII:2CN60TN6ZS


subject: UNII:2CN60TN6ZS

object_name: colorectal carcinoma


subject: UNII:2CN60TN6ZS

object_name: Stomach cancer


subject: UNII:2CN60TN6ZS


subject: UNII:2CN60TN6ZS


subject: UNII:2CN60TN6ZS


subject: UNII:2CN60TN6ZS


subject: UNII:2CN60TN6ZS


subject: UNII:2CN60TN6ZS


subject: UNII:2CN60TN6ZS


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: acute respiratory distress syndrome


subject: CHEBI:41879

object_name: adult acute respiratory distress syndrome


subject: CHEBI:41879

object_name: Coronavinae infectious disease


subject: CHEBI:41879

object_name: viral pneumonia


subject: UNII:406GR1485Z

object_name: prostate carcinoma


subject: UNII:406GR1485Z

object_name: prostate cancer


subject: UMLS:C3272775


subject: UMLS:C3272775


subject: CHEBI:135947

subject_name: Bazedoxifene

object_name: Postmenopausal symptoms


subject: CHEBI:135947

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:135947

object_name: obesity


subject: CHEBI:135947

object_name: Obesity, CTCAE


subject: CHEBI:8389

subject_name: conjugated estrogens


subject: CHEBI:8389


subject: CHEBI:8389


subject: CHEBI:8389


subject: PUBCHEM.COMPOUND:45357473

subject_name: Estratab


subject: PUBCHEM.COMPOUND:45357473


subject: PUBCHEM.COMPOUND:45357473


subject: PUBCHEM.COMPOUND:45357473


subject: CHEBI:3663


subject: CHEBI:3663


subject: CHEBI:3663


subject: CHEBI:3663


subject: CHEBI:33369

subject_name: cerium


subject: CHEBI:33369


subject: CHEBI:33369


subject: CHEBI:33369


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: Androgen excess


subject: PUBCHEM.COMPOUND:11306691

object_name: infertility


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:40237


subject: CHEBI:6801

subject_name: Metformin


subject: PUBCHEM.COMPOUND:85364156

object_name: Chronic constipation


subject: UMLS:C3886758


subject: CHEBI:35627

subject_name: beta-lactam

object_name: gram-negative bacterial infections


subject: CHEBI:91951

object_name: progesterone-receptor positive breast cancer


subject: CHEBI:91951

object_name: invasive breast carcinoma


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: CHEBI:61397

subject_name: Neratinib

object_name: Her2-receptor negative breast cancer


subject: CHEBI:61397

object_name: Carcinoma breast stage IV


subject: CHEBI:61397


subject: CHEBI:61397

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:61397


subject: UMLS:C2987342


subject: UMLS:C2987342

object_name: breast carcinoma


subject: UNII:4HA45S22ZZ

object_name: pancreatic neoplasm


subject: UNII:4HA45S22ZZ

object_name: benign neoplasm of pancreas


subject: UNII:4HA45S22ZZ

object_name: Pancreas problem


subject: CHEBI:67271


subject: CHEBI:67271


subject: CHEBI:67271


subject: CHEBI:29278

object_name: type 2 diabetes mellitus


subject: CHEBI:9241

subject_name: Spironolactone

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:9241

object_name: pulmonary hypertension


subject: CHEBI:9241

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:9241

object_name: pulmonary arterial hypertension


subject: UNII:NMZ08KM76Z

subject_name: Tropifexor


subject: PUBCHEM.COMPOUND:121418176


subject: UMLS:C5198715


subject: CHEBI:3077

subject_name: Betamethasone

object_name: psoriasis


subject: CHEBI:50749

subject_name: Calcipotriol


subject: MESH:C000719649


subject: CHEBI:193615

object_name: liver cancer


subject: CHEBI:193615

object_name: liver carcinoma


subject: CHEBI:60761

subject_name: Floxuridine


subject: CHEBI:60761


subject: UMLS:C4721874

subject_name: human insulin

object_name: type 1 diabetes mellitus 1


subject: UMLS:C4721874

object_name: type 1 diabetes mellitus


subject: UMLS:C0306371

subject_name: Humulin R


subject: UMLS:C0306371


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: cholangiocarcinoma


subject: UNII:28X28X9OKV

object_name: liver neoplasm


subject: UNII:28X28X9OKV

object_name: Adult Liver Carcinoma


subject: UNII:28X28X9OKV

object_name: biliary tract neoplasm


subject: UNII:28X28X9OKV

object_name: bile duct carcinoma


subject: UNII:28X28X9OKV

object_name: bile duct cancer


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:3752

subject_name: Clomifene


subject: CHEBI:3752

object_name: hypogonadotropic hypogonadism


subject: CHEBI:3752

object_name: Klinefelter syndrome


subject: CHEBI:84094

subject_name: testosterone sulfate


subject: CHEBI:84094


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: type 2 diabetes mellitus


subject: CHEBI:16347

object_name: Insulin resistance


subject: CHEBI:16347

object_name: end stage renal failure


subject: CHEBI:16347

object_name: Chronic uremia


subject: UMLS:C5418030

object_name: Seropositive rheumatoid arthritis


subject: PUBCHEM.COMPOUND:18218213

subject_name: QW


subject: CHEBI:141431

subject_name: Gln-Trp


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: multiple sclerosis


subject: CHEBI:195558

subject_name: Entrectinib

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:6931

subject_name: Midazolam


subject: UMLS:C4688355

subject_name: Mezagitamab

object_name: EXCESS LMW-DNA


subject: UMLS:C0279328

subject_name: Hyperbaric Oxygen (substance)

object_name: stroke disorder


subject: UMLS:C0279328

object_name: cerebrovascular disorder


subject: UMLS:C0279328

object_name: Stroke (heart beat)


subject: UMLS:C0279328

object_name: Stroke, CTCAE


subject: CHEBI:67271

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:67271

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:67271

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:67271

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:67271

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:67271

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:67271

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:67271

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:67271

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:67271

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:67271

object_name: adult acute monocytic leukemia


subject: CHEBI:67271

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:67271

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:67271

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:67271

object_name: Adult Erythroleukemia


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: oral cavity squamous cell carcinoma


subject: UNII:PQX0D8J21J

object_name: laryngeal squamous cell carcinoma


subject: UNII:PQX0D8J21J

object_name: oropharynx squamous cell carcinoma


subject: UNII:PQX0D8J21J

object_name: hypopharynx squamous cell carcinoma


subject: UNII:PQX0D8J21J

object_name: Sinus Cancer


subject: UNII:PQX0D8J21J

object_name: laryngeal carcinoma


subject: UNII:PQX0D8J21J

object_name: larynx cancer


subject: UNII:PQX0D8J21J

object_name: HPV positive oropharyngeal squamous cell carcinoma


subject: UNII:PQX0D8J21J

object_name: oral cavity carcinoma


subject: UNII:PQX0D8J21J

object_name: oral cavity cancer


subject: UNII:PQX0D8J21J

object_name: oropharyngeal carcinoma


subject: UNII:PQX0D8J21J

object_name: oropharynx cancer


subject: UNII:PQX0D8J21J

object_name: nasal cavity carcinoma


subject: UNII:PQX0D8J21J

object_name: nasal cavity cancer


subject: UNII:PQX0D8J21J

object_name: hypopharynx cancer


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654

object_name: head and neck squamous cell carcinoma


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: CHEBI:9168

subject_name: Sirolimus

object_name: EXCESS LMW-DNA


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Vomiting, CTCAE


subject: CHEBI:107736

object_name: Vomiting


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: UNII:DB1041CXDG

subject_name: BELANTAMAB

object_name: Relapsed/refractory multiple myeloma


subject: UMLS:C3826989


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab


subject: UMLS:C4287697


subject: CHEBI:68845

subject_name: Azilsartan medoxomil

object_name: hypertension


subject: CHEBI:68845

object_name: diabetes mellitus


subject: CHEBI:68845

object_name: Angina pectoris


subject: PUBCHEM.COMPOUND:53427024

subject_name: Arimoclomol

object_name: Gaucher disease type I


subject: PUBCHEM.COMPOUND:53427024

object_name: Gaucher disease type III


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: Liver Fibrosis


subject: UMLS:C1832024

subject_name: fermented wheat germ extract

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C1832024

object_name: Advanced Melanoma


subject: UMLS:C1832024

object_name: Advanced renal cell carcinoma


subject: UMLS:C1832024

object_name: Advanced Colorectal Carcinoma


subject: UMLS:C1832024

object_name: Advanced Triple-Negative Breast Carcinoma


subject: UMLS:C1832024

object_name: Stage IV Lung Cancer AJCC v8


subject: UMLS:C1832024

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C1832024

object_name: Stage III Lung Cancer AJCC v8


subject: UMLS:C1832024

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UMLS:C1832024

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: UMLS:C1832024

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: UMLS:C1832024

object_name: Advanced Lung Non-Small Cell Carcinoma


subject: UMLS:C1832024

object_name: Stage IV Colorectal Cancer AJCC v8


subject: UMLS:C1832024

object_name: Stage III Colorectal Cancer AJCC v8


subject: UMLS:C1832024

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C1832024

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Muscle Invasive Bladder Carcinoma


subject: UNII:DPT0O3T46P

object_name: Localized Malignant Neoplasm


subject: UMLS:C0042210

subject_name: Vaccines

object_name: adenomyosis


subject: UMLS:C0042210

object_name: endometriosis


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Recurrent Childhood Ependymoma


subject: CHEBI:4026

object_name: Recurrent Childhood Medulloblastoma


subject: CHEBI:4026

object_name: neoplastic meningitis


subject: CHEBI:4026

object_name: ependymoblastoma


subject: CHEBI:4026

object_name: Childhood Atypical Teratoid/Rhabdoid Tumor


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: MESH:C000627770

subject_name: folfirinox

object_name: Malignant neoplasm of pancreas resectable


subject: MESH:C000627770

object_name: pancreatic adenocarcinoma


subject: UNII:Y68179SY2L

object_name: neuroendocrine neoplasm


subject: UMLS:C2703172

subject_name: CF102 compound

object_name: liver carcinoma


subject: UMLS:C4305915

subject_name: Recombinant human relaxin

object_name: preeclampsia


subject: UNII:W0122B976Y

subject_name: SERELAXIN


subject: CHEBI:135810

subject_name: Atrasentan

object_name: prostate carcinoma


subject: CHEBI:135810

object_name: prostate cancer


subject: CHEBI:135810

object_name: esophageal adenocarcinoma


subject: CHEBI:135810

object_name: lung adenocarcinoma


subject: CHEBI:135810

object_name: cervical adenocarcinoma


subject: CHEBI:135810

object_name: adenocarcinoma


subject: CHEBI:135810

object_name: bile duct adenocarcinoma


subject: CHEBI:135810

object_name: gastric adenocarcinoma


subject: UNII:2R985002CT

subject_name: Mexidol

object_name: Chronic cerebral ischemia


subject: UMLS:C0128329

subject_name: mexidol


subject: CHEBI:7025

subject_name: Mupirocin

object_name: staphylococcal infection


subject: GTOPDB:9209

subject_name: zolbetuximab

object_name: Metastatic malignant neoplasm to pancreas


subject: GTOPDB:9209

object_name: pancreatic neoplasm


subject: GTOPDB:9209

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:9209

object_name: malignant pancreatic neoplasm


subject: GTOPDB:9209

object_name: Pancreatic adenocarcinoma metastatic


subject: UNII:TF5MPQ8WGY


subject: UNII:TF5MPQ8WGY


subject: UNII:TF5MPQ8WGY


subject: UNII:TF5MPQ8WGY


subject: UNII:TF5MPQ8WGY


subject: UMLS:C2827697


subject: UMLS:C2827697


subject: UMLS:C2827697


subject: UMLS:C2827697


subject: UMLS:C2827697


subject: CHEBI:7565

subject_name: Nifedipine

object_name: coronary artery disorder


subject: CHEBI:7565

object_name: coronary atherosclerosis


subject: CHEBI:7565

object_name: chronic kidney disease


subject: CHEBI:7565

object_name: Chronic uremia


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: squamous cell carcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: induced; birth


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:3757

subject_name: Clonidine

object_name: substance withdrawal syndrome


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE


subject: UMLS:C4548561

object_name: thalassemia


subject: DRUGBANK:DB14744

subject_name: Spirulina platensis

object_name: dyspepsia


subject: DRUGBANK:DB14744

object_name: Dyspepsia, CTCAE


subject: DRUGBANK:DB14744

object_name: Rebound acid hypersecretion


subject: DRUGBANK:DB14744

object_name: Heartburn


subject: CHEBI:53795

subject_name: (R)-amlodipine

object_name: essential hypertension


subject: UNII:WKM56H3TLB

subject_name: Myrcludex B

object_name: chronic hepatitis D infection


subject: PUBCHEM.COMPOUND:66621102

object_name: indolent B-cell non-Hodgkin lymphoma


subject: CHEBI:85089

subject_name: Ledipasvir


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: PUBCHEM.COMPOUND:77335690

subject_name: Velpatasvir


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: Visual Acuity


subject: CHEBI:8713

subject_name: Quinapril

object_name: hypertension


subject: CHEBI:8713

object_name: Hypertension, CTCAE


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists


subject: UMLS:C0001645


subject: CHEBI:55352

subject_name: (R)-Atenolol


subject: CHEBI:55352


subject: CHEBI:2904

subject_name: Atenolol


subject: CHEBI:2904


subject: CHEBI:35498

subject_name: diuretic


subject: CHEBI:35498


subject: UMLS:C0012798

subject_name: Diuretics


subject: UMLS:C0012798


subject: CHEBI:9637

subject_name: Torasemide


subject: CHEBI:9637


subject: CHEBI:5893

subject_name: Indapamide


subject: UMLS:C0906802

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib


subject: UNII:43Y934BBZ6

object_name: liver cirrhosis


subject: UMLS:C5557439

subject_name: Foscenvivint


subject: CHEBI:9168

subject_name: Sirolimus

object_name: microcystic lymphatic malformation


subject: CHEBI:9168

object_name: Venous-lymphatic malformation


subject: CHEBI:9168

object_name: tufted angioma


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: Stomach cancer


subject: MESH:C079198

object_name: gastric cancer


subject: CHEBI:231614

subject_name: Nivolumab

object_name: long COVID-19


subject: CHEBI:231614

object_name: hepatitis B


subject: CHEBI:231614

object_name: hepatitis C


subject: CHEBI:231614

object_name: HIV infection


subject: CHEBI:231614

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: UMLS:C0305066

subject_name: Human rabies vaccines

object_name: optic neuritis


subject: UMLS:C0305066

object_name: myelitis


subject: UMLS:C0305066

object_name: Myelitis, CTCAE


subject: UMLS:C0305066

object_name: transverse myelitis


subject: UMLS:C0305066

object_name: acute transverse myelitis


subject: UMLS:C4278474

object_name: atopic eczema


subject: PUBCHEM.COMPOUND:133604

subject_name: Collagen

object_name: Acute Pain


subject: PUBCHEM.COMPOUND:133604

object_name: Knee Injuries


subject: PUBCHEM.COMPOUND:133604

object_name: osteoarthritis, knee


subject: PUBCHEM.COMPOUND:133604

object_name: Chronic pain


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: CHEBI:3815


subject: CHEBI:3815


subject: CHEBI:3815


subject: CHEBI:3815


subject: UMLS:C0009325

subject_name: collagen


subject: UMLS:C0009325


subject: UMLS:C0009325


subject: UMLS:C0009325


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: cesarean section; complications


subject: CHEBI:8093

object_name: Complication of anesthesia


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: liver neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: Adult Liver Carcinoma


subject: UMLS:C5666970

subject_name: Anti-Wolbachia Agent AWZ1066S

object_name: onchocerciasis


subject: UMLS:C5666970

object_name: filarial elephantiasis


subject: UMLS:C5873071

object_name: X-linked retinitis pigmentosa


subject: DRUGBANK:DB16797

subject_name: Cotoretigene toliparvovec


subject: CHEBI:145499

subject_name: Donepezil

object_name: Postprocedural retention of urine


subject: CHEBI:74947

subject_name: Thalidomide

object_name: hereditary hemorrhagic telangiectasia


subject: CHEBI:74947

object_name: Epistaxis, CTCAE


subject: CHEBI:74947

object_name: Epistaxis


subject: CHEBI:180905

subject_name: Nicardipine

object_name: Acute Ischemic Stroke


subject: CHEBI:180905

object_name: Ischemic stroke


subject: CHEBI:167638

subject_name: Labetalol


subject: CHEBI:167638


subject: CHEBI:32278

subject_name: Urapidil


subject: CHEBI:32278


subject: CHEBI:8093


subject: CHEBI:8093


subject: CHEBI:6801

subject_name: Metformin

object_name: heart failure


subject: CHEBI:233364

subject_name: Bryostatin

object_name: Alzheimer disease type 1


subject: CHEBI:233364

object_name: Alzheimer disease


subject: CHEBI:88353

subject_name: Bryostatin 1


subject: CHEBI:88353


subject: PUBCHEM.COMPOUND:44277532

subject_name: Bryostatins


subject: PUBCHEM.COMPOUND:44277532


subject: CHEBI:94463

object_name: hepatitis B


subject: CHEBI:63580

subject_name: Ribavirin


subject: UNII:UMD07X179E

subject_name: CERTOLIZUMAB

object_name: ulcerative colitis


subject: UNII:UMD07X179E

object_name: inflammatory bowel disease 1


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Her2-receptor negative breast cancer


subject: CHEBI:5523

subject_name: Goserelin

object_name: HER2 positive breast carcinoma


subject: CHEBI:6413

subject_name: Letrozole


subject: UMLS:C5210630

subject_name: Pertuzumab Liquid Injection

object_name: Childhood Breast Carcinoma


subject: UMLS:C5210630

object_name: breast carcinoma


subject: UMLS:C5210630

object_name: breast cancer


subject: UMLS:C5210630


subject: UMLS:C5210630


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:41774


subject: UNII:SE2KH7T06F


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: peanut allergy


subject: UMLS:C0910794


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Dry age-related macular degeneration


subject: CHEMBL.COMPOUND:CHEMBL5314987

subject_name: GOTISTOBART

object_name: non-small cell lung carcinoma


subject: UMLS:C5417995

subject_name: Gotistobart


subject: UNII:OWV057OPZ3

subject_name: PARPI

object_name: ovarian cancer


subject: UNII:OWV057OPZ3

object_name: ovarian neoplasm


subject: UNII:OWV057OPZ3

object_name: ovarian carcinoma


subject: CHEBI:50162

subject_name: motexafin gadolinium hydrate

object_name: digestive system neoplasm


subject: CHEBI:50162

object_name: Neoplasm of the gastrointestinal tract


subject: CHEBI:50162

object_name: prostate cancer


subject: CHEBI:50162

object_name: prostate neoplasm


subject: CHEBI:50162


subject: CHEBI:50162


subject: CHEBI:50162

object_name: breast neoplasm


subject: CHEBI:50162

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:9919910

subject_name: Xcytrin


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: CHEBI:33375

subject_name: Gadolinium


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEMBL.COMPOUND:CHEMBL3544910

subject_name: MOTEXAFIN GADOLINIUM


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: cesarean section; complications


subject: CHEBI:7773

subject_name: Ondansetron


subject: UMLS:C4053577

subject_name: Sotevtamab

object_name: Childhood Solid Neoplasm


subject: UMLS:C4053577

object_name: Adult Solid Neoplasm


subject: UMLS:C4053577

object_name: Solid Neoplasm


subject: UMLS:C4053577

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4053577

object_name: Embolism, Tumor


subject: UMLS:C4053577

object_name: Neoplasm Metastasis


subject: CHEBI:8228

subject_name: Pioglitazone


subject: UNII:M170940PMI

subject_name: anetumab ravtansine

object_name: pancreatic adenocarcinoma


subject: UNII:M170940PMI

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:M170940PMI

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UNII:M170940PMI

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C3273944

subject_name: Anti-mesothelin antibody-drug conjugate BAY 94-9343


subject: UMLS:C3273944


subject: UMLS:C3273944


subject: UMLS:C3273944


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:91899

object_name: osteoporosis


subject: CHEBI:91899

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:91899

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:91899

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:3207


subject: CHEBI:3207


subject: CHEBI:3207


subject: CHEBI:9168

subject_name: Sirolimus

object_name: chronic graft versus host disease


subject: UNII:M170940PMI

object_name: ovarian cancer


subject: UNII:M170940PMI

object_name: ovarian neoplasm


subject: UMLS:C3273944


subject: UMLS:C3273944


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN

object_name: myocardial infarction


subject: UNII:E47C0NF7LV

object_name: Myocardial Infarction, CTCAE


subject: UNII:E47C0NF7LV

object_name: Myocardial Infarction by ECG Finding


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: grade 3A follicular lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:65173

subject_name: Iloperidone

object_name: bipolar I disorder


subject: GTOPDB:13316

subject_name: maridebart cafraglutide

object_name: obesity


subject: UNII:Z24U3U73HN

subject_name: MARIDEBART CAFRAGLUTIDE


subject: UMLS:C5855458

subject_name: Maridebart Cafraglutide


subject: CHEBI:185135

subject_name: Polyvidone

object_name: corneal ulcer


subject: CHEBI:185135

object_name: Corneal Ulcer, CTCAE


subject: CHEBI:185135

object_name: Bacterial keratitis


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: CHEBI:8347


subject: CHEBI:8347


subject: CHEBI:71954

subject_name: Buparlisib

object_name: lung cancer


subject: CHEBI:71954

object_name: lung neoplasm


subject: CHEBI:71954

object_name: lung carcinoma


subject: CHEBI:71954

object_name: colorectal cancer


subject: CHEBI:71954

object_name: colorectal carcinoma


subject: CHEBI:71954

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:71954

object_name: Solid Neoplasm


subject: CHEBI:71954

object_name: cholangiocarcinoma


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: spinal cord injury


subject: CHEBI:4953

subject_name: Exemestane

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C4722737

subject_name: AXS 05

object_name: endogenous depression


subject: UMLS:C4722737

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:50941212

subject_name: Avagacestat

object_name: Alzheimer disease type 1


subject: UMLS:C0001637

subject_name: Adrenergic Agents

object_name: Voiding Disorders


subject: UMLS:C0001637

object_name: Urinary Urgency


subject: PUBCHEM.COMPOUND:78357831

subject_name: micafungin

object_name: candidemia


subject: PUBCHEM.COMPOUND:78357831

object_name: candidiasis


subject: UMLS:C0879264


subject: UMLS:C0879264


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: arteriosclerosis disorder


subject: CHEBI:38545

object_name: aneurysm


subject: CHEBI:38545

object_name: heart disorder


subject: CHEBI:38545

object_name: hyperlipidemia


subject: CHEBI:38545

object_name: hyperlipoproteinemia


subject: CHEBI:38545

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:38545

object_name: Serum lipids high (finding)


subject: PUBCHEM.COMPOUND:91973920

subject_name: Grape Seed P.E.

object_name: dentin sensitivity


subject: MESH:D056604

subject_name: Grape Seed Extract


subject: DRUGBANK:DB16606

subject_name: Vitis vinifera seed


subject: UMLS:C4079992

object_name: xerophthalmia


subject: UMLS:C4079992

object_name: dry eye syndrome


subject: UMLS:C4079992

object_name: Dry Eye Syndrome, CTCAE


subject: UMLS:C1619357

subject_name: Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries

object_name: vascular dementia


subject: UMLS:C1619357

object_name: Lewy Bodies


subject: UMLS:C1619357

object_name: Pick Complex


subject: UMLS:C1619357

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C1619357

object_name: frontotemporal dementia


subject: UMLS:C1619357

object_name: Pick disease


subject: UMLS:C1619357

object_name: Alzheimer disease


subject: PUBCHEM.COMPOUND:129887057


subject: PUBCHEM.COMPOUND:129887057


subject: PUBCHEM.COMPOUND:129887057


subject: PUBCHEM.COMPOUND:129887057


subject: PUBCHEM.COMPOUND:129887057


subject: PUBCHEM.COMPOUND:129887057


subject: PUBCHEM.COMPOUND:129887057


subject: UNII:K6396E6G8G


subject: UNII:K6396E6G8G


subject: UNII:K6396E6G8G


subject: UNII:K6396E6G8G


subject: UNII:K6396E6G8G


subject: UNII:K6396E6G8G


subject: UNII:K6396E6G8G


subject: UNII:7P55415B0R


subject: UNII:7P55415B0R


subject: UNII:7P55415B0R


subject: UNII:7P55415B0R


subject: UNII:7P55415B0R


subject: UNII:7P55415B0R


subject: UNII:7P55415B0R


subject: UMLS:C4521177


subject: UMLS:C4521177


subject: UMLS:C4521177


subject: UMLS:C4521177


subject: UMLS:C4521177


subject: UMLS:C4521177


subject: UMLS:C4521177


subject: PUBCHEM.COMPOUND:23279496

subject_name: uridine triacetate


subject: PUBCHEM.COMPOUND:23279496


subject: PUBCHEM.COMPOUND:23279496


subject: PUBCHEM.COMPOUND:23279496


subject: PUBCHEM.COMPOUND:23279496


subject: PUBCHEM.COMPOUND:23279496


subject: PUBCHEM.COMPOUND:23279496


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]

object_name: endogenous depression


subject: UMLS:C3536908

object_name: major depressive disorder


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: chronic hepatitis B virus infection


subject: UNII:9MX546E2SF

object_name: adult acute myeloid leukemia


subject: UNII:9MX546E2SF

object_name: childhood acute myeloid leukemia


subject: UNII:9MX546E2SF

object_name: acute myeloid leukemia


subject: CHEBI:74076

subject_name: Ile-Pro

object_name: influenza


subject: CHEBI:82335


subject: CHEBI:17660

subject_name: ENADENINE


subject: UMLS:C4049997


subject: PR:000014564

subject_name: succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: interstitial lung disease


subject: CHEBI:70746

object_name: scleroderma


subject: CHEBI:70746

object_name: systemic sclerosis


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:119915

subject_name: Fentanyl

object_name: cancer pain


subject: CHEBI:16349

subject_name: Citrulline

object_name: diabetes mellitus, ketosis-prone


subject: UMLS:C4305779

object_name: Urinary Urgency


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: hypertension


subject: CHEBI:192614

object_name: Hypertension, CTCAE


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: Inherited platelet disorder


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: pancreatitis


subject: CHEBI:7986

object_name: Pancreatitis, CTCAE 5.0


subject: CHEBI:7986

object_name: Pancreatitis, CTCAE 3.0


subject: CHEBI:147398

subject_name: Tideglusib

object_name: myotonic dystrophy type 1


subject: CHEBI:147398

object_name: congenital myotonic dystrophy


subject: UNII:2GFP9BJD79

subject_name: Glucarpidase

object_name: primary central nervous system lymphoma


subject: PUBCHEM.COMPOUND:75038

object_name: Vascular calcification


subject: PUBCHEM.COMPOUND:75038

object_name: Complication of hemodialysis


subject: PUBCHEM.COMPOUND:75038

object_name: Deficiency of vitamin K2


subject: CHEBI:44245

subject_name: Menaquinone 7


subject: CHEBI:44245


subject: CHEBI:44245


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C2930155

subject_name: ARTEMISIA

object_name: Psychogenic dysphonia


subject: UMLS:C1704263

subject_name: green tea extract


subject: UMLS:C2346810

object_name: glioblastoma


subject: UMLS:C2346810

object_name: Brain Stem Glioblastoma


subject: UMLS:C2346810

object_name: glioma susceptibility 1


subject: UNII:089658A12D

subject_name: Guselkumab

object_name: psoriasis


subject: CHEBI:91472

object_name: Chagas disease


subject: CHEBI:7566

subject_name: Nifurtimox


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: migraine


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Pancreatic carcinoma non-resectable


subject: UNII:28X28X9OKV

object_name: Locally Advanced Pancreatic Carcinoma


subject: UNII:28X28X9OKV

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: outcomes general quality of life


subject: PUBCHEM.COMPOUND:134506

object_name: Perceived quality of life


subject: PUBCHEM.COMPOUND:134506

object_name: Good quality of life


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28689


subject: MESH:D010919

subject_name: Placebos


subject: MESH:D010919


subject: MESH:D010919


subject: CHEBI:5134

subject_name: Fluticasone

object_name: atopic conjunctivitis


subject: UMLS:C1996347

subject_name: Saline Nasal Spray


subject: UMLS:C0723613

subject_name: Tears Naturale


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Childhood Pilomyxoid Astrocytoma


subject: UNII:2S9ZZM9Q9V

object_name: pilomyxoid astrocytoma


subject: UNII:2S9ZZM9Q9V

object_name: low grade glioma


subject: UNII:2S9ZZM9Q9V

object_name: astrocytoma


subject: UNII:2S9ZZM9Q9V

object_name: childhood pilocytic astrocytoma


subject: UNII:2S9ZZM9Q9V

object_name: Adult Pilocytic Astrocytoma


subject: UNII:2S9ZZM9Q9V

object_name: Spongioblastoma


subject: UNII:2S9ZZM9Q9V

object_name: brain stem glioma


subject: UNII:2S9ZZM9Q9V

object_name: Grade III Childhood Astrocytoma


subject: UNII:2S9ZZM9Q9V

object_name: Adult Anaplastic Astrocytoma


subject: UNII:2S9ZZM9Q9V

object_name: anaplastic astrocytoma


subject: UNII:2S9ZZM9Q9V

object_name: optic nerve glioma


subject: UNII:2S9ZZM9Q9V

object_name: diffuse midline glioma, H3 K27M-mutant


subject: UNII:2S9ZZM9Q9V

object_name: diffuse intrinsic pontine glioma


subject: UNII:2S9ZZM9Q9V

object_name: diffuse astrocytoma


subject: UNII:2S9ZZM9Q9V

object_name: pleomorphic xanthoastrocytoma


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Pleomorphic Xanthoastrocytoma


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Childhood Pilomyxoid Astrocytoma


subject: CHEBI:31355

object_name: pilomyxoid astrocytoma


subject: CHEBI:31355

object_name: low grade glioma


subject: CHEBI:31355

object_name: astrocytoma


subject: CHEBI:31355

object_name: childhood pilocytic astrocytoma


subject: CHEBI:31355

object_name: Adult Pilocytic Astrocytoma


subject: CHEBI:31355

object_name: Spongioblastoma


subject: CHEBI:31355

object_name: brain stem glioma


subject: CHEBI:31355

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:31355

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:31355

object_name: anaplastic astrocytoma


subject: CHEBI:31355

object_name: optic nerve glioma


subject: CHEBI:31355

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:31355

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:31355

object_name: diffuse astrocytoma


subject: CHEBI:31355

object_name: pleomorphic xanthoastrocytoma


subject: CHEBI:31355

object_name: Childhood Pleomorphic Xanthoastrocytoma


subject: CHEBI:31355

object_name: glioblastoma


subject: CHEBI:31355

object_name: Brain Stem Glioblastoma


subject: CHEBI:31355

object_name: Adult Gliosarcoma


subject: CHEBI:31355

object_name: gliosarcoma


subject: CHEBI:31355

object_name: Childhood Gliosarcoma


subject: CHEBI:8988

object_name: Childhood Pilomyxoid Astrocytoma


subject: CHEBI:8988

object_name: pilomyxoid astrocytoma


subject: CHEBI:8988

object_name: low grade glioma


subject: CHEBI:8988

object_name: astrocytoma


subject: CHEBI:8988

object_name: childhood pilocytic astrocytoma


subject: CHEBI:8988

object_name: Adult Pilocytic Astrocytoma


subject: CHEBI:8988

object_name: Spongioblastoma


subject: CHEBI:8988

object_name: brain stem glioma


subject: CHEBI:8988

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:8988

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:8988

object_name: anaplastic astrocytoma


subject: CHEBI:8988

object_name: optic nerve glioma


subject: CHEBI:8988

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:8988

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:8988

object_name: diffuse astrocytoma


subject: CHEBI:8988

object_name: pleomorphic xanthoastrocytoma


subject: CHEBI:8988

object_name: Childhood Pleomorphic Xanthoastrocytoma


subject: CHEBI:8988

object_name: Brain Stem Glioblastoma


subject: CHEBI:8988

object_name: glioma susceptibility 1


subject: CHEBI:8988

object_name: Adult Gliosarcoma


subject: CHEBI:8988

object_name: gliosarcoma


subject: CHEBI:8988

object_name: Childhood Gliosarcoma


subject: CHEBI:80630

subject_name: Irinotecan

object_name: Childhood Pilomyxoid Astrocytoma


subject: CHEBI:80630

object_name: pilomyxoid astrocytoma


subject: CHEBI:80630

object_name: low grade glioma


subject: CHEBI:80630

object_name: astrocytoma


subject: CHEBI:80630

object_name: childhood pilocytic astrocytoma


subject: CHEBI:80630

object_name: Adult Pilocytic Astrocytoma


subject: CHEBI:80630

object_name: Spongioblastoma


subject: CHEBI:80630

object_name: brain stem glioma


subject: CHEBI:80630

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:80630

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:80630

object_name: anaplastic astrocytoma


subject: CHEBI:80630

object_name: optic nerve glioma


subject: CHEBI:80630

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:80630

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:80630

object_name: diffuse astrocytoma


subject: CHEBI:80630

object_name: pleomorphic xanthoastrocytoma


subject: CHEBI:80630

object_name: Childhood Pleomorphic Xanthoastrocytoma


subject: CHEBI:80630

object_name: Brain Stem Glioblastoma


subject: CHEBI:80630

object_name: glioma susceptibility 1


subject: CHEBI:80630

object_name: Adult Gliosarcoma


subject: CHEBI:80630

object_name: gliosarcoma


subject: CHEBI:80630

object_name: Childhood Gliosarcoma


subject: CHEBI:6704

subject_name: Mebendazole

object_name: Childhood Pilomyxoid Astrocytoma


subject: CHEBI:6704

object_name: pilomyxoid astrocytoma


subject: CHEBI:6704

object_name: low grade glioma


subject: CHEBI:6704

object_name: astrocytoma


subject: CHEBI:6704

object_name: childhood pilocytic astrocytoma


subject: CHEBI:6704

object_name: Adult Pilocytic Astrocytoma


subject: CHEBI:6704

object_name: Spongioblastoma


subject: CHEBI:6704

object_name: brain stem glioma


subject: CHEBI:6704

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:6704

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:6704

object_name: anaplastic astrocytoma


subject: CHEBI:6704

object_name: optic nerve glioma


subject: CHEBI:6704

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:6704

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:6704

object_name: diffuse astrocytoma


subject: CHEBI:6704

object_name: pleomorphic xanthoastrocytoma


subject: CHEBI:6704

object_name: Childhood Pleomorphic Xanthoastrocytoma


subject: CHEBI:6704

object_name: glioblastoma


subject: CHEBI:6704

object_name: Brain Stem Glioblastoma


subject: CHEBI:6704

object_name: glioma susceptibility 1


subject: CHEBI:6704

object_name: Adult Gliosarcoma


subject: CHEBI:6704

object_name: gliosarcoma


subject: CHEBI:6704

object_name: Childhood Gliosarcoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Childhood Pilomyxoid Astrocytoma


subject: UMLS:C0919079

object_name: pilomyxoid astrocytoma


subject: UMLS:C0919079

object_name: childhood pilocytic astrocytoma


subject: UMLS:C0919079

object_name: Adult Pilocytic Astrocytoma


subject: UMLS:C0919079

object_name: Spongioblastoma


subject: UMLS:C0919079

object_name: brain stem glioma


subject: UMLS:C0919079

object_name: Grade III Childhood Astrocytoma


subject: UMLS:C0919079

object_name: Adult Anaplastic Astrocytoma


subject: UMLS:C0919079

object_name: optic nerve glioma


subject: UMLS:C0919079

object_name: diffuse midline glioma, H3 K27M-mutant


subject: UMLS:C0919079

object_name: diffuse intrinsic pontine glioma


subject: UMLS:C0919079

object_name: diffuse astrocytoma


subject: UMLS:C0919079

object_name: pleomorphic xanthoastrocytoma


subject: UMLS:C0919079

object_name: Childhood Pleomorphic Xanthoastrocytoma


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658

object_name: low grade glioma


subject: CHEBI:143658

object_name: astrocytoma


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658

object_name: anaplastic astrocytoma


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658

object_name: glioblastoma


subject: CHEBI:143658

object_name: Brain Stem Glioblastoma


subject: CHEBI:143658

object_name: glioma susceptibility 1


subject: CHEBI:143658

object_name: Adult Gliosarcoma


subject: CHEBI:143658

object_name: gliosarcoma


subject: CHEBI:143658

object_name: Childhood Gliosarcoma


subject: CHEBI:28445

subject_name: vincristine

object_name: Childhood Pilomyxoid Astrocytoma


subject: CHEBI:28445

object_name: pilomyxoid astrocytoma


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445

object_name: childhood pilocytic astrocytoma


subject: CHEBI:28445

object_name: Adult Pilocytic Astrocytoma


subject: CHEBI:28445

object_name: Spongioblastoma


subject: CHEBI:28445

object_name: brain stem glioma


subject: CHEBI:28445

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:28445

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:28445


subject: CHEBI:28445

object_name: optic nerve glioma


subject: CHEBI:28445

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:28445

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:28445

object_name: diffuse astrocytoma


subject: CHEBI:28445

object_name: pleomorphic xanthoastrocytoma


subject: CHEBI:28445

object_name: Childhood Pleomorphic Xanthoastrocytoma


subject: CHEBI:28445

object_name: glioblastoma


subject: CHEBI:28445

object_name: Brain Stem Glioblastoma


subject: CHEBI:28445

object_name: glioma susceptibility 1


subject: CHEBI:28445

object_name: Adult Gliosarcoma


subject: CHEBI:28445

object_name: gliosarcoma


subject: CHEBI:28445

object_name: Childhood Gliosarcoma


subject: DRUGBANK:DB16329

subject_name: siG12D LODER

object_name: pancreatic ductal adenocarcinoma


subject: DRUGBANK:DB16329

object_name: pancreatic neoplasm


subject: DRUGBANK:DB16329

object_name: exocrine pancreatic carcinoma


subject: DRUGBANK:DB16329

object_name: malignant pancreatic neoplasm


subject: UMLS:C2976397

object_name: interstitial lung disease 1


subject: UMLS:C2976397

object_name: interstitial lung disease 2


subject: CHEBI:3638

subject_name: Chloroquine


subject: CHEBI:3638

object_name: Childhood Glioblastoma


subject: CHEBI:3638

object_name: adult glioblastoma


subject: CHEBI:3638


subject: CHEBI:3638


subject: CHEBI:3638


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: localized osteosarcoma


subject: CHEBI:72317

object_name: Secondary Osteosarcoma


subject: CHEBI:72317

object_name: Metastatic osteosarcoma


subject: CHEBI:72317

object_name: High Grade Osteosarcoma


subject: UMLS:C0440016

subject_name: Allergenic extract

object_name: Wheezing


subject: UMLS:C0440016

object_name: Wheezing, CTCAE


subject: UMLS:C0440016

object_name: Allergy


subject: UMLS:C0440016

object_name: History of allergies


subject: UMLS:C0440016

object_name: asthma


subject: GTOPDB:8088

subject_name: epratuzumab

object_name: EXCESS LMW-DNA


subject: CHEMBL.COMPOUND:CHEMBL2108404

subject_name: EPRATUZUMAB


subject: UMLS:C0281743


subject: CHEBI:41423

subject_name: Celecoxib

object_name: liver carcinoma


subject: CHEBI:45783

subject_name: Imatinib

object_name: melanoma


subject: UMLS:C4042170

object_name: Erdheim-Chester disease


subject: UMLS:C4042170

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C4042170

object_name: non-Hodgkin lymphoma


subject: UMLS:C4042170

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C4042170

object_name: Childhood Non-Hodgkin Lymphoma